title: Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.
abstract: BACKGROUND
  Patients with haematological malignancy admitted to intensive care have a high mortality. Adverse prognostic factors include the number of organ failures, invasive mechanical ventilation and previous bone marrow transplantation. Severity-of-illness scores may underestimate the mortality of critically ill patients with haematological malignancy. This study investigates the relationship between admission characteristics and outcome in patients with haematological malignancies admitted to intensive care units (ICUs) in England, Wales and Northern Ireland, and assesses the performance of three severity-of-illness scores in this population.
  
  
  METHODS
  A secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme Database was conducted on admissions to 178 adult, general ICUs in England, Wales and Northern Ireland between 1995 and 2007. Multivariate logistic regression analysis was used to identify factors associated with hospital mortality. The Acute Physiology and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology Score (SAPS) II and ICNARC score were evaluated for discrimination (the ability to distinguish survivors from nonsurvivors); and the APACHE II, SAPS II and ICNARC mortality probabilities were evaluated for calibration (the accuracy of the estimated probability of survival).
  
  
  RESULTS
  There were 7,689 eligible admissions. ICU mortality was 43.1% (3,312 deaths) and acute hospital mortality was 59.2% (4,239 deaths). ICU and hospital mortality increased with the number of organ failures on admission. Admission factors associated with an increased risk of death were bone marrow transplant, Hodgkin's lymphoma, severe sepsis, age, length of hospital stay prior to intensive care admission, tachycardia, low systolic blood pressure, tachypnoea, low Glasgow Coma Score, sedation, PaO2:FiO2, acidaemia, alkalaemia, oliguria, hyponatraemia, hypernatraemia, low haematocrit, and uraemia. The ICNARC model had the best discrimination of the three scores analysed, as assessed by the area under the receiver operating characteristic curve of 0.78, but all scores were poorly calibrated. APACHE II had the highest accuracy at predicting hospital mortality, with a standardised mortality ratio of 1.01. SAPS II and the ICNARC score both underestimated hospital mortality.
  
  
  CONCLUSIONS
  Increased hospital mortality is associated with the length of hospital stay prior to ICU admission and with severe sepsis, suggesting that, if appropriate, such patients should be treated aggressively with early ICU admission. A low haematocrit was associated with higher mortality and this relationship requires further investigation. The severity-of-illness scores assessed in this study had reasonable discriminative power, but none showed good calibration.
authors.affiliation: Royal Liverpool University Hospital, Prescot Street, Liverpool, L7 8XP, UK. drphampshire@hotmail.com
authors.forename: Peter A
authors.initials: PA
authors.lastname: Hampshire
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Welch
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: McCrossan
authors.forename: Katharine
authors.initials: K
authors.lastname: Francis
authors.forename: David A
authors.initials: DA
authors.lastname: Harrison
mesh_terms: D000328:Adult; D000368:Aged; D003422:Critical Care; D005260:Female; D019337:Hematologic Neoplasms / Q000401:mortality*; D006751:Hospital Information Systems; D017052:Hospital Mortality; D006757:Hospital Units; D006801:Humans; D008297:Male; D008875:Middle Aged; D010343:Patient Admission; D012720:Severity of Illness Index; D006113:United Kingdom
references.citation: N Engl J Med. 2001 Nov 8;345(19):1368-77
references.pmid: 11794169
references.citation: Blood. 2001 Dec 1;98(12):3234-40
references.pmid: 11719359
references.citation: Crit Care. 2004 Apr;8(2):R99-111
references.pmid: 15025784
references.citation: Acta Anaesthesiol Scand. 2003 Mar;47(3):301-6
references.pmid: 12648196
references.citation: Chest. 1988 Jul;94(1):99-102
references.pmid: 3383663
references.citation: Eur J Cancer. 1997 Jun;33(7):1031-7
references.pmid: 9376183
references.citation: J Clin Oncol. 1999 Mar;17(3):991-7
references.pmid: 10071294
references.citation: Br J Anaesth. 2001 Oct;87(4):543-8
references.pmid: 11878722
references.citation: Br J Cancer. 1991 Nov;64(5):938-42
references.pmid: 1931620
references.citation: Intensive Care Med. 1998 Dec;24(12):1283-8
references.pmid: 9885881
references.citation: Intensive Care Med. 1990;16(5):291-7
references.pmid: 2212252
references.citation: Chest. 2004 Nov;126(5):1604-11
references.pmid: 15539734
references.citation: Crit Care Med. 2003 Sep;31(9):2332-8
references.pmid: 14501964
references.citation: Chest. 1993 Aug;104(2):527-31
references.pmid: 8339643
references.citation: J Clin Oncol. 1998 Feb;16(2):761-70
references.pmid: 9469368
references.citation: Intensive Care Med. 2002 Dec;28(12):1775-80
references.pmid: 12447522
references.citation: Support Care Cancer. 2005 May;13(5):332-8
references.pmid: 15864663
references.citation: Intensive Care Med. 2006 Oct;32(10):1560-8
references.pmid: 16896863
references.citation: Chest. 2002 Jan;121(1):185-8
references.pmid: 11796449
references.citation: Eur J Haematol. 2005 Jun;74(6):511-6
references.pmid: 15876255
references.citation: Eur Respir J. 1998 Jul;12(1):116-22
references.pmid: 9701425
references.citation: Chest. 2004 Oct;126(4):1299-306
references.pmid: 15486396
references.citation: Crit Care Med. 1985 Oct;13(10):818-29
references.pmid: 3928249
references.citation: Swiss Med Wkly. 2001 Dec 22;131(47-48):681-6
references.pmid: 11875752
references.citation: Intensive Care Med. 2002 Sep;28(9):1294-300
references.pmid: 12209280
references.citation: Crit Care Med. 2006 May;34(5):1378-88
references.pmid: 16557153
references.citation: Support Care Cancer. 2003 Nov;11(11):686-95
references.pmid: 12905057
references.citation: Anaesthesia. 2005 Apr;60(4):340-7
references.pmid: 15766336
references.citation: Crit Care Med. 2002 Oct;30(10):2260-70
references.pmid: 12394954
references.citation: Radiology. 1982 Apr;143(1):29-36
references.pmid: 7063747
references.citation: Crit Care Med. 2008 Mar;36(3):690-6
references.pmid: 18431262
references.citation: Intensive Care Med. 1999 Dec;25(12):1395-401
references.pmid: 10660847
references.citation: Crit Care Med. 2007 Apr;35(4):1091-8
references.pmid: 17334248
references.citation: Intensive Care Med. 2003 Oct;29(10):1688-95
references.pmid: 13680115
references.citation: Am J Respir Crit Care Med. 1998 Sep;158(3):876-84
references.pmid: 9731020
references.citation: Ann Intern Med. 1996 Oct 15;125(8):625-33
references.pmid: 8849146
references.citation: Br Med J (Clin Res Ed). 1988 Apr 9;296(6628):1025-9
references.pmid: 3130123
references.citation: Chest. 1999 Oct;116(4):1012-8
references.pmid: 10531167
references.citation: J Clin Oncol. 2006 Feb 1;24(4):643-9
references.pmid: 16380411
references.citation: Crit Care Med. 2003 Jan;31(1):104-12
references.pmid: 12545002
references.citation: JAMA. 1993 Dec 22-29;270(24):2957-63
references.pmid: 8254858
references.citation: N Engl J Med. 2001 Feb 15;344(7):481-7
references.pmid: 11172189
references.citation: N Engl J Med. 1999 Feb 11;340(6):409-17
references.pmid: 9971864
references.citation: Crit Care Med. 2006 May;34(5):1297-310
references.pmid: 16540951
references.citation: Br J Haematol. 2007 Feb;136(3):448-50
references.pmid: 17156405